 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
BD Diagnostics Division Sees 5 Percent Growth in FY Q1, but MDx Not Yet a Major Driver
February 07, 2013
BD Diagnostics Division Sees 5 Percent Growth in FY Q1, but MDx Not Yet a Major Driver
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Becton Dickinson Looks to Serve Several Market Segments as it Builds Out Molecular Testing Pipeline
January 3, 2013 / PCR Insider - BD Diagnostics Execs Update Molecular Pipeline; New Tests for BD MAX and Viper on Horizon
August 9, 2012 / PCR Insider - BD Diagnostics, Diagenode Launch BD Max Flu A/B Test in Europe
November 8, 2012 / PCR Insider - Hologic's Gen-Probe Wins Judgment in IP Suit Against BD, but Dispute Remain Unresolved
October 4, 2012 / PCR Insider - Dx Focus: Roche Cobas p 630; Abbott Plex-ID System; Trio of New C. Diff Tests; MDI's MRSA Panel
April 5, 2012 / PCR Insider